April 10, 2019 Venture funding slowdown continues in first quarter of 2019 Venture funding drops again, but there’s no need to panic yet.
August 30, 2018 Seeking alpha in PI3K inhibition Novartis hails the most advanced alpha-directed PI3K inhibitor after success in breast cancer, but it’s not the only one.
